Abstract:PURPOSE: The emergence of bacteria that are resistant to many currently used drugs emphasizes the need to discover and develop new antibiotics that are effective against such multi-resistant strains. Kendomycin is a novel polyketide that has a unique quinone methide ansa structure and various biological properties. This compound exhibits strong antibacterial activity against Gram-negative and Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Despite the promise of kendomycinin in several therapeutic areas, its mode of action has yet to be identified.METHODS: In this study, we used a multidisciplinary approach to gain insight into the antibacterial mechanism of this compound.RESULTS: The antibacterial activity of kendomycin appears to be bacteriostatic rather than bactericidal. Kendomycin inhibited the growth of the MRSA strain COL at a low concentration (MIC of 5 μg/mL). Proteomic analysis and gene transcription profiling of kendomycin-treated cells indicated that this compound affected the regulation of numerous proteins and genes involved in central metabolic pathways, such as the tricarboxylic acid (TCA) cycle (SdhA) and gluconeogenesis (PckA and GapB), cell wall biosynthesis and cell division (FtsA, FtsZ, and MurAA), capsule production (Cap5A and Cap5C), bacterial programmed cell death (LrgA and CidA), the cellular stress response (ClpB, ClpC, ClpP, GroEL, DnaK, and GrpE), and oxidative stress (AhpC and KatA). Electron microscopy revealed that kendomycin strongly affected septum formation during cell division. Most kendomycin-treated cells displayed incomplete septa with abnormal morphology.CONCLUSIONS: Kendomycin might directly or indirectly affect the cell division machinery, protein stability, and programmed cell death in S. aureus. Additional studies are still needed to obtain deeper insight into the mode of action of kendomycin.

Flavin-Dependent Monooxygenase Kmy13 Mediates Formation of the Carbocyclic ansa System during Kendomycin B Biosynthesis

A Type I/Type III Polyketide Synthase Hybrid Biosynthetic Pathway for the Structurally Unique ansa Compound Kendomycin

Identification and Heterologous Expression of the Kendomycin B Biosynthetic Gene Cluster from Verrucosispora sp. SCSIO 07399

Kinamycin biosynthesis employs a conserved pair of oxidases for B-ring contraction

Strategies for construction of the all-carbon macrocyclic skeleton of the ansamycin antibiotic—kendomycin

New Kendomycin Derivative Isolated from Streptomyces sp. Cl 58-27

Two distinct epoxide ring opening pathways in a monocyclic model system of the kedarcidin chromophore

A study on the structure, mechanism, and biochemistry of kanamycin B dioxygenase (KanJ)—an enzyme with a broad range of substrates

A BBE-like Oxidase, AsmF, Dictates the Formation of Naphthalenic Hydroxyl Groups in Ansaseomycin Biosynthesis.

Catalysis of Extracellular Deamination by a FAD‐Linked Oxidoreductase after Prodrug Maturation in the Biosynthesis of Saframycin A

Reconstitution Of Kinamycin Biosynthesis Within The Heterologous Host Streptomyces Albus J1074

Investigations to the Antibacterial Mechanism of Action of Kendomycin

Structure and Function of a C-C Bond Cleaving Oxygenase in Atypical Angucycline Biosynthesis

Efficient biosynthesis of nucleoside cytokinin angustmycin A containing an unusual sugar system

Structure and Function of Mycobacterium Smegmatis 7-Keto-8-aminopelargonic Acid (KAPA) Synthase

A vitamin K-dependent carboxylase orthologue is involved in antibiotic biosynthesis

Flavoprotein hydroxylase PgaE catalyzes two consecutive oxygen-dependent tailoring reactions in angucycline biosynthesis

Characterization of the Flavoenzyme XiaK As an N-hydroxylase and Implications in Indolosesquiterpene Diversification.

Elucidation of the di-c-glycosylation steps during biosynthesis of the antitumor antibiotic, kidamycin

Dual Carbamoylations On The Polyketide And Glycosyl Moiety By Asm21 Result In Extended Ansamitocin Biosynthesis

An Unusual Aromatase/cyclase Programs the Formation of the Phenyldimethylanthrone Framework in Anthrabenzoxocinones and Fasamycin.